ADULT ALL

Clinical trials for ADULT ALL explained in plain language.

Never miss a new study

Get alerted when new ADULT ALL trials appear

Sign up with your email to follow new studies for ADULT ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 2

New hope for rare leukemia: targeted combo aims to boost survival

Disease control Not yet recruiting

This study tests a new treatment for adults with a rare leukemia called acute leukemia of ambiguous lineage (ALAL). The treatment combines targeted drugs (blinatumomab, venetoclax, and possibly TKI drugs) with standard chemotherapy. The goal is to see if this approach improves su…

Matched conditions: ADULT ALL

Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated May 26, 2026 06:25 UTC

ADULT ALL

Get alerted when new ADULT ALL trials appear

New hope for rare leukemia: targeted combo aims to boost survival